Lab Members

Kelly Banas

Kelly Banas, Ph.D.

Principal Investigator

B.S. University of Delaware

MLS (ASCP)CM

Ph.D. University of Delaware

Kelly Banas's research interests are in developing and evaluating novel gene editing strategies in non-small cell lung cancer. Her current focus is on targeting cancer specific NRF2 mutations with CRISPR gene editing tools and evaluating the short and long-term effects these specific targeting strategies have on affected and neighboring cells. Kelly’s seminal discovery of a unique CRISPR target site within tumor cells that is absent in normal cell surrounding the tumor, has established an innovative foundational approach to the treatment of solid tumors by CRISPR-directed gene editing. She is currently working on developing this approach towards Investigational New Drug status. She graduated from the University of Delaware with a Ph.D. in Molecular Medicine in 2021.